American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors.

Sharaiha RZ, Shukla AP, Sen S, et al. American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors.. Gastrointestinal endoscopy. 2025;101(2):285-294.

Publisher's Version

Last updated on 10/08/2025
PubMed

Walter W. Chan, MD, MPH, FACG, AGAF, FAFS

Associate Professor of Medicine, Harvard Medical School

Director, Center for Gastrointestinal Motility, Brigham and Women's Hospital

Director, Clinical Research Education, Division of Gastroenterology, Hepatology and Endoscopy

American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors.

Walter W. Chan, MD, MPH

Navigation

Contact Information